November 7, 2025 · Form 4 insider transaction
JOHNSON & JOHNSON sold 200 shares of CVRX at $10.00 per share, a transaction worth $2.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.